# The Physiological Effects of FGF21 on Alcohol Preference and Glucose Metabolism

> **NCT04232033** · NA · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 20 (actual)

## Conditions studied

- Fibroblast Growth Factor 21
- Tast Perference

## Interventions

- **OTHER:** Fibroblast growth factor 21 infusion
- **OTHER:** Placebo infusion (saline)

## Key facts

- **NCT ID:** NCT04232033
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-01
- **Primary completion:** 2022-06-14
- **Final completion:** 2024-12-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04232033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04232033, "The Physiological Effects of FGF21 on Alcohol Preference and Glucose Metabolism". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04232033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*